Log In
BCIQ
Print this Print this
 

MM-111

  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionBispecific antibody targeting erb-b2 receptor tyrosine kinase 3 (ERBB3; HER3; EGFR3) and EGFR2
Molecular Target Erb-b2 receptor tyrosine kinase 3 (ERBB3) (HER3) (EGFR3) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor agonist; Epidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor; Bispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today